27 research outputs found

    Chemokine CXCL-1 Expression in the Subretinal Fluid during Rhegmatogenous Retinal Detachment

    No full text
    Purpose: To investigate the expression of chemokine CXCL-1 in the subretinal fluid (SRF) during rhegmatogenous retinal detachment (RRD) and identify potential correlations with number of quadrants involved and duration of the detachment. Methods and Results: Inclusion criteria were patients aged 18 years or older and primary RRD possibly complicated by proliferative vitreoretinopathy (PVR). CXCL-1 levels were measured in 36 SRF samples from 36 RRD patients. Mean CXCL-1 levels (102 +/- 37 pg/mL) were significantly higher (p = 0.050) compared to controls. CXCL-1 levels correlated significantly with age (p = 0.001) and RRD duration (p = 0.002). Maximum CXCL-1 levels coincided with total RRD, 29- to 60-day duration and PVR grade C. Conclusions: The findings of this study may contribute to increased understanding regarding the role of CXCL-1 during the onset and progression of the wound healing process in the context of RRD and PVR

    Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy

    No full text
    Purpose: To investigate the levels of IL-6 in the vitreous of patients with RRD complicated with PVR and correlate the IL-6 levels with matrix metalloproteinase (MMP)-1,-2,-3,-8,-9 and tissue inhibitor of metalloproteinases (TIMP)-1 with respect to RRD extent, duration and PVR grade. Design: Cohort study. Participants: Twenty-eight vitreous samples from 28 eyes of 28 patients with RRD complicated with PVR. Methods: Institutional study. Twenty-eight vitreous samples from 28 eyes of 28 patients with RRD complicated with PVR were collected during pars plana vitrectomy (PPV) and were compared to vitreous control samples. IL-6. MMP-1,-3,-8 and TIMP-1 levels were measured using ELISA while enzymatic activity of MMP-2, and -9 was determined employing gelatin zymography. Results: Protein IL-6 (p = 0.030), MMP-1 (p = 0.003), MMP-3 (p = 0.003), TIMP-1 (p = 0.001) levels as well as enzymatic activity of proMMP-9 (p = 0.013), MMP-9 (p = 0.017) and proMMP-2 (p = 0.010), were significantly increased in PVR patients as compared to controls. IL-6 levels correlated with MMP-1 (p = 0.002), proMMP-2 (p = 0.006), MMP-3 (p = 0.001) and TIMP-1 (p = 0.006). Regression analysis revealed positive correlations between IL-6 and all MMPs and TIMP-1. Conclusions: Taking into account the previously established effect of interleukins in MMP activity, the findings of this study suggest a role of IL-6 in MMP stimulation during PVR development. (C) 2011 Elsevier Ltd. All rights reserved
    corecore